Announced and pending backlog up 2.5x, but the market remains skeptical as the stock is down ~19% over the last 90 days.
PWP · Earnings Call · 2026-07-31
The Numbers Look Backward, the Backlog Looks Forward
Perella Weinberg's Q2 2026 headline results were soft: revenue of $157M brought first-half revenue to $305M, down 17% year-over-year. Yet CEO Andrew Bednar was unambiguous that the reported figures are a lagging indicator. The firm’s booked plus announced and pending backlog is up over 30% from a year ago, while the announced and pending backlog alone has nearly tripled. This divergence between reported revenue and forward indicators is the core story of the quarter.
Announced transactions have picked up significantly. We are running ahead of where we were at this point in 2025. The pace has accelerated this summer, with nearly 40% of our year-to-date announcements occurring since the start of June.
The acceleration is idiosyncratic to the sectors and clients PWP has invested in—industrials, consumer, healthcare, and infrastructure—rather than a broad market tailwind. As “Andrew explained, they are "market share takers, not tethered to the broader market," and the build-out of those franchises is now paying off” — Andrew Bednar, Chief Executive Officer and Chairman · 2026-07-31. The tone is notably more concrete than the cautious, wait-and-see language of prior quarters.
Why This Matters: The Forward Engine Is Turning Over
The market has punished PWP this year—the stock is down ~19% over the last 90 days and ~37% from its January 2025 peak. The company's own price tape shows a persistent downtrend, but management is pointing to catalysts that should eventually convert into revenue.
One structural driver is the maturity wall: “"The number of companies facing significant 2029 and 2030 maturities and increasing rating agency pressure is larger than ever," which should keep the financing and capital solutions business robust” — Andrew Bednar, Chief Executive Officer and Chairman · 2026-07-31. This echoes the private equity and liability management themes that have been consistent across recent calls.
Positioning also improved with the Gleacher Shacklock acquisition and a new partner class. Over a third of the partnership is still in the ramp-up phase, but management stresses that these investments are the product: “Our products actually get more valuable over time” — Andrew Bednar, Chief Executive Officer and Chairman · 2026-07-31. They remain committed to the 67% compensation ratio target for the full year despite a 71% first-half accrual.
From a fundamentals perspective, the trajectory is still weak, but there are early signs of stabilization. Total revenue is -30% y/y in the most recent quarter, but the sequential decline is moderating and the company is holding its guidance. The balance sheet is clean with $116M cash and no debt, and capital returns continue—$73M returned to shareholders year to date.
Risks and the Market's Doubt
The market's pessimism is not unfounded. The comp ratio is elevated, margins are thin (Operating margin was -8.7% in Q1 2026, versus +10% at the 2021 peak), and the promise of backlog conversion has been delayed before. Analysts in prior calls have repeatedly pressed on the timing of large fee events, and management has acknowledged that timeline risk is inherent. The difference this time is the sheer size of the announced pipeline and the fact that a meaningful chunk of it (nearly 40% of YTD announcements) occurred in just the last six weeks—a pattern not seen in prior quarters.
The global macro backdrop also supports the narrative: one of the top global keywords for 20263 is "Batch Zero" in the context of ERCOT, but more importantly, the tape shows a broad pick-up in announced M&A across the industry. PWP is positioned as a share taker, but the tide is rising.
Verdict
Perella Weinberg's Q2 report is a classic story of leading indicators versus lagging ones. The market has been wrong to be so uniformly negative given the backlog surge, but the company has also burned investors with delayed conversions before. This quarter, the evidence is stronger: acceleration in announcements, a record A&P backlog, and a clear catalyst in the maturity wall. If even half of the announced backlog converts in the next 12-18 months, the stock is substantially undervalued. The risk is that timeline slippage persists, but the direction of travel is now unmistakable.